Nature medicine

• 

  Año 2006, Número 1

  • Foxa2, a novel transcriptional regulator of insulin sensitivity

    J. T. Rodgers, P. Puigserver

    págs. 38-39

    

  • ARNT misbehavin' in diabetic beta cells

    M. P. Czech

    págs. 39-40

    

  • Stressed out about obesity and insulin resistance

    C. de Luca, J. M. Olefsky

    págs. 41-42

    

  • The humoral side of insulin resistance

    Mitchell A. Lazar

    págs. 43-44

    

  • Improving metabolism by increasing energy expenditure

    J. Auwerx

    págs. 44-45

    

  • Fast predators or fast food, the fit still survive

    C. F. Semenkovich, C. Bernal-Mizrachi

    págs. 46-47

    

  • How diabetes went to our heads

    R. J. Seeley

    págs. 47-49

    

  • Did a muscle fuel gauge conquer the brain?

    Luciano Rossetti, E. D. Muse, A. Pocai

    págs. 50-51

    

  • Developmental programming of the hypothalamus: a matter of fat

    T. L. Horvath, J. C. Bruning

    págs. 52-53

    

  • When the Clock stops ticking, metabolic syndrome explodes

    B. Staels

    págs. 54-55

    

  • Klotho-induced insulin resistance: a blessing in disguise?

    R. H. Unger

    págs. 56-57

    

  • Notable metabolism papers 2003-2005

    págs. 58-61

    

  • Epidemiologic and economic consequences of the global epidemics of obesity and diabetes

    D. Yach, D. Stuckler, K. D. Brownell

    págs. 62-66

    

  • NIH research on obesity and type 2 diabetes: providing the scientific evidence base for actions to improve health

    A. M. Spiegel

    págs. 67-69

    

  • Diabetes research investment in the European Union

    P. A. Halban, E. Ferrannini

    págs. 70-72

    

  • Combating diabetes and obesity in Japan

    Y. Yazaki, T. Kadowaki

    págs. 73-74

    

  • Diabetes and obesity: the twin epidemics

    A. Heron, S. Smyth

    págs. 75-80

    

  • Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase

    J. Strahilevitz, A. Robicsek

    págs. 83-88

    

  • Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation

    J. J. Trowbridge

    págs. 89-98

    

  • IL-13 signaling through the IL-13¿2 receptor is involved in induction of TGF-ß1 production and fibrosis

    S. Fichtner-Feigl

    págs. 99-106

    

  • TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes

    H. Shimano, T. Yoshikawa, Y. Nakagawa

    págs. 107-113

    

  • A role for the scaffolding adapter GAB2 in breast cancer

    M. Bentires-Alj

    págs. 114-121

    

  • Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer

    George Thomas

    págs. 122-127

    

  • A crucial role of mitochondrial Hsp40 in preventing dilated cardiomyopathy

    M. Hayashi, K Imanaka Yoshida

    págs. 128-132

    

  • Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice

    K. Yamamoto

    págs. 133-137

    

  • Lipid microarrays identify key mediators of autoimmune brain inflammation

    S. Narayana, J. L. Kanter

    págs. 138-143

    

  • In vivo imaging of islet transplantation

    N. V. Evgenov

    págs. 144-148